2027 Licensing Public Health 
Hall Render
JUNE 5, 2024
Stage 2: Effective May 6, 2026 Two years after the Final Rule’s publication, the FDA will expand its regulatory scope to include establishment registration and listing, labeling and investigational use requirements. Part 820), providing added oversight over the quality management of LDTs.
NY Health Law
FEBRUARY 13, 2024
That application, which is the successor to the state’s Delivery System Reform Incentive Payment (DSRIP) Program that expired in March 2020, was first described in a concept paper issued by the Department of Health (DOH) in August 2021, and was filed with CMS in September 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SQA
FEBRUARY 15, 2023
ICMRA recognizes that AMR is a complex, multifaceted problem and calls for better coordination across all sectors, including public health, animal health, and the environment, through a ‘One Health’ approach. Tackling AMR is one of ICMRA’s strategic priorities.
SQA
MAY 24, 2023
The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. Following adoption by the European Council, the formal process of publication in the OJEU may begin, and typically takes up to 30 days.
SQA
MAY 24, 2023
The deadline for reporting serious incidents not constituting serious public health threats, deaths, or unanticipated serious deteriorations in state of health was reduced to 15 calendar days. Following adoption by the European Council, the formal process of publication in the OJEU may begin, and typically takes up to 30 days.
SQA
OCTOBER 18, 2024
NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding public health.
SQA
OCTOBER 18, 2024
NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding public health.
Expert insights. Personalized for you.
40 
Let's personalize your content